Alana D Carpenter
Overview
Explore the profile of Alana D Carpenter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
66
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Carpenter A, Li Y, Miranda I, Wise S, Fatanmi O, Petrus S, et al.
Radiat Res
. 2025 Jan;
203(2):83-95.
PMID: 39786949
BBT-059 is a long-acting PEGylated interleukin-11 analog that has been shown to have hematopoiesis-promoting and anti-apoptotic attributes, and is being studied as a radiation countermeasure for the hematopoietic acute radiation...
2.
Chakraborty N, Dimitrov G, Kanan S, Lawrence A, Moyler C, Gautam A, et al.
PLoS One
. 2024 Nov;
19(11):e0311379.
PMID: 39570918
Multiple accidents in nuclear power plants and the growing concerns about the misuse of radiation exposure in warfare have called for the rapid determination of absorbed radiation doses (RDs). The...
3.
Carpenter A, Empfield K, Petrus S, Fatanmi O, Wise S, Tyburski J, et al.
Sci Rep
. 2024 Oct;
14(1):23930.
PMID: 39397118
Exposure to ionizing radiation induces cellular and molecular damage leading to a cascade of events resulting in tissue and organ injury. Our study strives to characterize and validate metabolomic changes...
4.
Tichy A, Carpenter A, Li Y, Rydlova G, Rehulka P, Markova M, et al.
Int J Mol Sci
. 2024 Sep;
25(17).
PMID: 39273157
In the last decade, geopolitical instability across the globe has increased the risk of a large-scale radiological event, when radiation biomarkers would be needed for an effective triage of an...
5.
Carpenter A, Fatanmi O, Wise S, Tyburski J, Cheema A, Singh V
Sci Rep
. 2024 Jun;
14(1):13571.
PMID: 38866887
The identification and validation of radiation biomarkers is critical for assessing the radiation dose received in exposed individuals and for developing radiation medical countermeasures that can be used to treat...
6.
Singh V, Wise S, Fatanmi O, Petrus S, Carpenter A, Lugo-Roman L, et al.
Sci Rep
. 2024 Jun;
14(1):13315.
PMID: 38858439
Exposure to high, marginally lethal doses or higher of ionizing radiation, either intentional or accidental, results in injury to various organs. Currently, there is only a limited number of safe...
7.
Carpenter A, Li Y, Wise S, Fatanmi O, Petrus S, Fam C, et al.
Radiat Res
. 2024 May;
202(1):26-37.
PMID: 38714310
BBT-059, a long-acting PEGylated interleukin-11 (IL-11) analog that is believed to have hematopoietic promoting and anti-apoptotic properties, is being developed as a potential radiation medical countermeasure (MCM) for hematopoietic acute...
8.
Singh V, Wise S, Fatanmi O, Petrus S, Carpenter A, Lee S, et al.
Sci Rep
. 2024 Mar;
14(1):5757.
PMID: 38459144
Despite remarkable scientific progress over the past six decades within the medical arts and in radiobiology in general, limited radiation medical countermeasures (MCMs) have been approved by the United States...
9.
Russ E, Fatanmi O, Wise S, Carpenter A, Maniar M, Iordanskiy S, et al.
Sci Rep
. 2024 Feb;
14(1):4518.
PMID: 38402257
Exposure to ionizing radiation (IR) presents a formidable clinical challenge. Total-body or significant partial-body exposure at a high dose and dose rate leads to acute radiation syndrome (ARS), the complex...
10.
Carpenter A, Li Y, Fatanmi O, Wise S, Petrus S, Janocha B, et al.
Radiat Res
. 2024 Jan;
201(5):371-383.
PMID: 38253059
A complex cascade of systemic and tissue-specific responses induced by exposure to ionizing radiation can lead to functional impairment over time in the surviving population. Current methods for management of...